STARTUP GETS FUNDING FOR INHALABLE DRUG DEVICE

An aerosol drug delivery method invented to fight pandemic disease outbreaks may be adapted to treat everything from asthma to diabetes, thanks to new financing for an Atlanta startup. AerovectRx Corp. will use its first round of venture funding to refine the technology -- developed at the Centers for Disease Control and Prevention and already cleared by the Food and Drug Administration -- for commercial use.

Atlanta Business Chronicle (http://www.bizjournals.com/atlanta/stories/2006/09/11/story12.html?b=1157947200%5e1342376)